Approvals/CIMA-AEMPS/DAPTOMICINA CIPLA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

Approved

STANDARD

DAPTOMICINA CIPLA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

Cipla Europe🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: c53131ee11e4a774
Drug Cima Aemps Name: DAPTOMICINA CIPLA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG
Register Number: 85751
Holder Company Name: Cipla Europe
Marketing Company Name: Cipla Europe Nv Sucursal En Espana
Authorization Date: 2021-02-03
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose: 350 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Cipla Europe

DAPTOMICINA

350 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 3, 2021

Approval ID

c53131ee11e4a774

Type

Standard